Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms

Blood Cancer Journal

Volumn 1, Issue 8, 2011, Pages

  Brecqueville, M ^a,b   Cervera, N ^a   Adelaide J ^a   Rey, J ^a   Carbuccia, N ^a   Chaffanet, M ^a   Mozziconacci, M J ^a   Vey, N ^a,b   Birnbaum, D ^a   Gelsi Boyer, V ^a,b   Murati, A ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; HYDROXYUREA; POLYCOMB GROUP PROTEIN; SUZ12 PROTEIN; UNCLASSIFIED DRUG;

AGED; BLOOD SAMPLING; CANCER STAGING; CASE REPORT; CHROMOSOME 17Q; CHROMOSOME ANALYSIS; CHRONIC MYELOMONOCYTIC LEUKEMIA; EXON; GENE DELETION; HEMATOPOIETIC STEM CELL; HISTONE MODIFICATION; HUMAN; KARYOTYPE; LETTER; LEUKEMOGENESIS; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOPROLIFERATIVE NEOPLASM; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PSEUDOGENE; SEQUENCE ANALYSIS; THROMBOCYTHEMIA;

EID: 84857042600     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2011.31     Document Type: Letter

References (12)

1. Acquaviva C, Gelsi-Boyer V, Birnbaum D. Myelodysplastic syndromes: lost between two states? Leukemia 2010; 24: 1-5.
2. Tefferi A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010; 24: 1128-1138.
3. Vainchenker W, Delhommeau F, Constantinescu SN, Bernard OA. New mutations and pathogenesis of myeloproliferative neoplasms. Blood 2011, (in press).
4. Margueron R, Reinberg D. The polycomb complex PRC2 and its mark in life. Nature 2011; 469: 343-349.
5. Gelsi-Boyer V, Trouplin V, Adelaide J, Bonansea J, Cervera N, Carbuccia N et al. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol 2009; 145: 788-800.
6. Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 2010; 42: 722-726.
7. Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, Tonnissen ER et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet 2010; 42: 665-667.
8. Gelsi-Boyer V, Trouplin V, Adélaïde J, Aceto N, Remy V, Pinson S et al. Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. BMC Cancer 2008; 8: 299-314.
9. Brecqueville M, Cervera N, Gelsi-Boyer V, Murati A, Adélaïde J, Chaffanet M et al. Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes. Blood Cancer J 2011; 1: e18.
10. Klampfl T, Harutyunyan A, Berg T, Gisslinger B, Schalling M, Bagienski K et al. Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Blood 2011; 118: 167-176.
11. Majewski IJ, Blewitt ME, de Graaf CA, McManus EJ, Bahlo M, Hilton AA et al. Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity. PLoS Biol 2008; 6: e93.
12. Yamamoto K, Sonoda M, Inokuchi J, Shirasawa S, Sasazuki T. Polycomb group suppressor of Zeste 12 links heterochromatin protein 1a and enhancer of Zeste 2. J Biol Chem 2004; 279: 401-406. (Pubitemid 38044839)